TEVA 8199 TEVA 8199 Pill: maroon, capsule/oblong, 14mm
The pill with imprint TEVA 8199 TEVA 8199 (Maroon, Capsule/Oblong, 14mm) has been identified as Sunitinib Malate 12.5 mg and is used for Renal Cell Carcinoma, Gastrointestinal Stromal Tumor, and Pancreatic Cancer. It belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors and is not a controlled substance.
Images for TEVA 8199 TEVA 8199
Sunitinib Malate
- Imprint
- TEVA 8199 TEVA 8199
- Strength
- 12.5 mg
- Color
- Maroon
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-8199
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
mannitol,
povidone k30,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
gelatin,
titanium dioxide,
ferrosoferric oxide,
D&C Yellow No. 10 Aluminium Lake,
FD&C Blue No. 1 Aluminium Lake,
FD&C Blue No. 2 Aluminium Lake,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
See also:
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.